Objective: The aim of this study was to evaluate the psychometric properties of the Menopause-Specific Quality of Life Questionnaire (MENQOL) in a sample of breast cancer survivors experiencing menopausal symptoms.
T he Menopause-Specific Quality of Life Questionnaire (MENQOL) was introduced in 1996 as a tool to assess health-related quality of life in the immediate postmenopausal period. An inherent assumption of the MENQOL is that disease states and conditions like menopause, which produce symptoms, may disrupt the emotional, physical, and social aspects of an individual's life, which must be considered concomitantly with treatment decisions. The MENQOL improves upon several instruments used to assess the impact of menopausal symptoms on quality of life, including the Kupperman index and the General Well-Being Scale, in the following ways: (1) specificity to the condition of menopause;
(2) item development based upon women's own qualitative and quantitative accounts of menopausal symptoms; (3) inclusion of all pertinent domains of the menopause experience, including sexual symptoms; and (4) demonstrated reliability and validity. 1 The MENQOL is self-administered and consists of a total of 29 items in a Likert-scale format. Each item assesses the impact of one of four domains of menopausal symptoms, as experienced over the last month: vasomotor (items 1-3), psychosocial (items 4-10), physical (items [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] , and sexual (items [27] [28] [29] . Items pertaining to a specific symptom are rated as present or not present, and if present, how bothersome on a 0 (not bothersome) to 6 (extremely bothersome) scale. 1, 2 Means are computed for each subscale by dividing the sum of the domain's items by the number of items within that domain. 2 Nonendorsement of an item is scored a 1; and endorsement, a 2, plus the number of the particular rating, so that the possible score on any item ranges from 1 to 8.
Despite the MENQOL's widespread use and established reliability and validity among women experiencing naturally occurring menopause, 1,2 its psychometric properties have not been evaluated in a population of breast cancer survivors.
However, menopause frequently occurs because of cancer treatment, including chemotherapy, radiation, oophorectomy, and hysterectomy. Although the prevalence of and physiological mechanism inducing menopausal symptoms are thought to be similar between naturally occurring and treatmentinduced menopause, 3, 4 the transition may be accelerated 4<6 and symptoms may be intensified 7 in those who have undergone cancer therapy. Numerous qualitative and quantitative accounts corroborate the negative impact of menopausal symptoms on quality of life in this group. 5 
,8<13

METHODS
The purpose of this analysis was to evaluate the psychometric properties of the MENQOL in a sample of breast cancer survivors experiencing menopausal symptoms, enabling an appraisal of the instrument's usability in such a population. MENQOL data were combined from two separate, consecutive randomized placebo-controlled trials examining the effectiveness of acupuncture on menopausal symptoms in women previously treated for breast cancer. Both studies compared quality of life and reduction in menopausal symptom frequency and severity among participants randomized to one of three conditions: an education control, an acupuncture body siteYspecific intervention, or an acupuncture body siteYnonspecific placebo. Frequency and severity of menopausal symptoms were measured via daily symptom diaries, the Kupperman index, and the MENQOL, all administered at baseline, as well as at various follow-up points throughout each study. Study 1 followed participants (n = 39) over 26 weeks, administering the MENQOL at baseline and weeks 11 and 26. Study 2 followed participants (n = 69) over 22 weeks, administering the MENQOL at baseline and weeks 5, 9, and 22. A total of 108 participants were included in baseline analyses. Two participants were lost to follow-up within the combined education control, the group used to determine testretest reliability. Participants with missing data for a particular analysis were excluded from that analysis. To minimize confounding of quality of life assessment with cancer treatment, participants in each study must not have been undergoing active chemotherapy at time of enrollment. Potential participants were also excluded if they screened positive for depression at baseline via the Center for Epidemiologic Studies Depression Scale or had undergone acupuncture or taken any hormonal or herbal supplements within the previous 3 months. Eligibility requirements included endorsement of hot flashes, as identified on the baseline symptom diary, and treatment for breast cancer within the last 12 months.
Baseline data screening
Age, age at menopause, time since last menstrual period (LMP), menopause etiology, any chemotherapy, stage of breast cancer at diagnosis, and type of breast cancer were assessed and compared between the two studies using means, SDs, and independent-samples t tests for continuous data and percentages and W 2 tests for categorical data. For each instrument item, univariate normality was assessed through Shapiro-Wilkes tests and visual examination of boxplots and histograms. A screening for multivariate outliers indicated no influential cases; thus, all data were retained for analyses. An interitem correlation matrix was examined for values exceeding 0.70, indicative of item redundancy. 14 
Reliability
Internal consistency reliability
To assess the extent to which each subscale of the MENQOL measured a similar construct, internal consistency reliability with Cronbach > was computed for each subscale at baseline.
Test-retest reliability
Within the education control group, test-retest reliability was evaluated for each subscale using two methods: intraclass correlation coefficients (ICCs) and Pearson product-moment (PM) correlations (r), similar to the approach taken by the MENQOL's developers. 1 PM correlations are reported because their interpretation tends to be more intuitive; however, ICCs were also computed with the recognition that test-retest scores are nonindependent measures, a theoretical violation of r. In addition, the ICC provides a way to calculate test-retest reliability with multiple retests. A two-way random effects model was used in computing the ICCs, as sources of error variance could be identified, 15 including time since LMP and chemotherapy treatment. Because of the divergent times at which the retest MENQOLs were administered between the two studies, ICCs and r's were calculated for both the separate and combined study samples. The third MENQOL administration in study 1 at 26 weeks was not included in test-retest calculations because of excessive elapsed time.
Validity
Principal components analysis
Principal components analysis with oblique promax rotation was performed for the baseline MENQOL administration to determine if the latent item structure mirrored the four domains specified in the instrument's construction. Promax rotation was used because of the high number of component intercorrelations, indicating that factors would probably be correlated. A Kaiser-Meyer-Olkin statistic of 0.696 indicated that factor analysis was appropriate for the data, 16 and the Bartlett test of sphericity was significant, suggesting the absence of multicollinearity. The number of extracted components was determined by the scree plot, percentage of variance explained by each component, number of eigenvalues over one (Kaiser-Guttman rule), and consideration of prior psychometric MENQOL analyses. Items were considered representative of a component if their individual item loading was 0.50 or greater. Cross-loading items were those items that loaded 0.30 or greater on two or more components. 17 
Convergent and discriminant validity
Convergent and discriminant validities were assessed for the vasomotor and psychosocial domains of the MENQOL at baseline via PM correlations between the respective subscale scores and several concurrent measures representing vasomotor and psychosocial quality of life. A similar assessment for the physical or sexual subscales was precluded by the absence of comparative measures.
To establish vasomotor domain convergent validity, vasomotor items of the Kupperman index (Bhot flashes[ and Bprofuse perspiration[) and daily symptom diary (Bhot flashes[ and Bnight sweats[) were correlated with the vasomotor subscale scores of the MENQOL in a method similar to that used by Lewis et al. 2 In the Kupperman index, menopausal symptoms are given a score on a scale from 0 to 3, corresponding to Bnot present[ to Bsevere.[ This score is multiplied by a constant, indicative of the relative importance attributed to the specific symptom. 18 In this analysis, the averages of the combined hot flash and profuse perspiration scores were the basis for correlation.
The daily symptom diary measures severity of hot flashes and night sweats on the same 0-to-3 scale used by Kupperman. These scores are multiplied by daily frequency of symptoms. In this analysis, participants recorded in the diary before randomization for 7 days. An average for both symptoms was computed for this period by summing the products of severity and frequency and dividing by seven. These individual symptom means were then combined into an average that became the basis for correlation. Later, a post hoc individual item mean correlation was performed to observe if this would improve the low combined symptom convergent correlation.
To assess psychosocial domain convergent validity, psychosocial subscale scores were correlated with the 7-day average of the Bmood change[ item of the daily symptom diary and select items of the Kupperman index (weighted combined score from the items Bnervous irritability[ and Bdepressive moods[). Discriminant validity was assessed for both the vasomotor and psychosocial domains via correlations of the respective subscales with the psychosocial and vasomotor items of the Kupperman index and symptom diary.
RESULTS
Sample and item characteristics
The two samples included within this analysis did not differ significantly in any baseline variables, except for type and stage of breast cancer. See Table 1 for sample baseline characteristics.
Univariate normality was violated for each item of the MENQOL, consistent with expectations for dichotomous items embedded within Likert-scale type formats. 19, 20 Specifically, the vasomotor items and item 14 (Bdifficulty sleeping[) were negatively skewed, indicative of item endorsement and an accompanying high degree of interference in quality of life. All other items were positively skewed. Only one redundancy (r = 0.738) was noted from the interitem correlation matrix: items 13 (Bfeeling tired or worn out[) and 17 (Bdecrease in stamina[). Both items were retained in the analyses to facilitate comparisons to past psychometric work with the MENQOL.
Reliability
Internal consistency reliability
The Cronbach > for each subscale is displayed in Table 2 . For all subscales, > values were between 0.710 and 0.850 without any item deletions, except the sexual subscale, whose > value improved to 0.710 with the removal of item 28 (Bvaginal dryness[). The value 0.70 is considered the lower threshold for adequate internal consistency reliability for an established instrument. 21 Test-retest reliability PM and ICC test-retest reliability correlations are presented in Table 3 . ICCs at the combined first follow-up ranged from 0.616 on the sexual subscale to 0.822 on the vasomotor subscale, and all were significant at the > = 0.05 level. Overall, r's were lower than ICCs. ICCs and r's were more often significant and consistently higher for the week 5 to 9 period than from baseline to either of these follow-up points for all study 2 subscales. The ICCs for the combined three follow-up periods in study 2 were higher than 0.720 and significant at > G 0.01 for each domain. Study 1 r's and ICCs failed to reach significant levels for the sexual, physical, or vasomotor subscales (with the exception of r in the vasomotor subscale). 
Validity
Principal components analysis
The scree plot suggested extraction of eight factors, whereas nine eigenvalues exceeded 1 and explained 69.6% of the variance. Item loadings in the component, pattern, and structure matrix with nine extracted components revealed the emergence of three to four strong components that explained just less than 50% of the variance. Here, we report item loadings from the pattern matrix. Table 4 for individual item loadings according to the specified factor structure.
Convergent and discriminant validity
With regard to convergent validity, the Baseline to first follow-up (study 1 = week 11; study 2 = week 5) Baseline to week 9
Week 5 to week 9 Baseline to week 5 to week 9 Combined studies 1 and 2
Individual studies 1 and 2 Table 5 ).
DISCUSSION
In this analysis, the MENQOL exhibited adequate to good internal consistency reliability on all subscales except the sexual domain, moderate to high test-retest reliabilities in all domains at the combined first follow-up point, and an underlying factor structure generally mirroring the domains specified by the MENQOL, except in the physical domain. Convergent validity was established for the vasomotor and psychosocial subscales with the Kupperman index, which was Items with one or more cross-loadings (ie, loadings of Q0.30 on components other than the primary/highest loading item).
less evident for the daily symptom diary. Discriminant validity for these subscales was also supported. Overall, the pooled age at onset of menopause in this analysis was lower than reported in previous MENQOL work, 1, 2 and most participants reported a pathological cause of menopause, as expected. Study differences in staging and types of cancer may be attributable to the large number of unclassified cancers in study 1, rather than true group differences. Because there were no other sample differences, the two groups could be combined for most analyses. The negative skewing of the vasomotor items is expected because of the strong, direct relationship between vasomotor symptoms and the physiological basis of menopause. In addition, Bdifficulty sleeping[ (item 14) is very closely tied to the phenomenon of night sweats, 22, 23 which would account for the negative skew of this item.
The internal consistency reliabilities of the psychosocial and physical subscales in this analysis were approximately equal to those reported by Lewis et al 2 and Hilditch et al, 1 whereas the vasomotor and sexual subscales were considerably less, but similar to results reported in an analysis of an adapted version of the MENQOL. 24 Notably, that study had a sample of women with a range of ages comparable to our analysis. The discrepancy in the sexual and vasomotor subscales may also be due to their brevity, decreased response rate, nonendorsement of the sexual items (possibly a result of their stronger relationship to natural aging, particularly item 28, Bvaginal dryness[), and the acceleration of and variable nature of vasomotor symptoms among breast cancer survivors. Although also problematic in the factor analysis, consideration of item 28 for removal (or grouping with another subscale) warrants further investigation in this population, as any deletion in such a small subscale may decrease internal consistency reliability. 25 Combined study test-retest reliabilities for each subscale from baseline to first follow-up tended to be slightly less than those reported by Lewis et al, 2 Hilditch et al, 1 or Gelfand et al. 24 The wide variability of individual test-retest reliabilities among both domain and study is probably due to several factors, including the small number of participants, the 6-week difference between the two studies at first follow-up, retest periods beyond the 2 to 4 weeks reported by the other studies, and the possibility that menopause symptoms in breast cancer survivors behave in a more state-than trait-like fashion. 4<6 In addition, the test-retest reliabilities of study 2 tended to be lower when the baseline measurement was taken into account. This suggests a sensitization effect, a point strengthened by the fact that participants did not regularly complete the daily symptom diary until week 5.
In the principal components analysis, almost all items in the vasomotor, psychosocial, and sexual subscale loaded strongly and exclusively in their respective domains. Physical subscale items loaded on multiple components, and in several cases, at least three of these items could be combined to identify a new component. For example, items 12, 15, and 24 might be termed aches, whereas the items in the second component block might be called dryness ( Table 4 ). Elimination of other physical subscale items based upon this analysis, however, is premature; to our knowledge, a formal factor analysis procedure has never been undertaken for the MENQOL, and our sample size is on the smaller end of the continuum suggested for meaningful factor analysis results. Although our combined sample had more than 100 participants and a subjects-to-items ratio of 3.7:1, meeting the acceptable standard for factor analysis according to several sources, 1, 26 Nunnally and Bernstein 21 suggest a sample size of at least 4-5:1. In addition, a theoretical controversy exists about the suitability of factor analysis for quality of life scales. 27, 28 The moderate correlation between the vasomotor items of the Kupperman index and the MENQOL to establish convergent validity is similar to that reported by Lewis et al. 2 As they noted, correlation was probably attenuated by comparing two items in the Kupperman index to the MENQOL's three. In addition, the Kupperman index differs from the MENQOL in its intended administration via interview, absence of a clearly defined recall period, and scarcity of psychometric data. 18 Conversely, the Kupperman psychosocial domain correlation displays good convergent validity. This domain discrepancy may be due to the weightings applied to the multiplicative constants of the Kupperman vasomotor items, compared with the constant of 1 assigned to both psychosocial items of the Kupperman index. The latter format is more comparable to the MENQOL.
Failure of the symptom diary items to achieve high convergent validity with the MENQOL's vasomotor and psychosocial subscale items is probably due to differences in the recall periods between the instruments (1 d vs 1 mo) and the intended measurement intervals (7 d vs 1 mo). Moreover, sample size for the symptom diary is somewhat less than for the other comparisons of convergent validity.
CONCLUSIONS
This analysis examined the psychometric properties of the MENQOL in a population of breast cancer survivors. Overall, the instrument performed nearly as well in this subgroup as the target population of women experiencing natural menopause. To confirm these results and incorporate the MENQOL into breast cancer research, psychometric analysis with a larger sample of women, in whom menopausal symptoms may be more exclusively attributed to cancer treatment, is indicated.
